fludarabine and Leukoencephalopathy Syndrome, Posterior

fludarabine has been researched along with Leukoencephalopathy Syndrome, Posterior in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Revel, T; Doghmi, K; Jennane, S; Konopacki, J; Mahtat, el M; Malfuson, JV; Mikdame, M1
Morgensztern, D; Peddi, PF; Peddi, S; Santos, ES1
Beitinjaneh, A; Cao, Q; McKinney, AM; Weisdorf, DJ1

Reviews

2 review(s) available for fludarabine and Leukoencephalopathy Syndrome, Posterior

ArticleYear
Central nervous system toxicities of chemotherapeutic agents.
    Expert review of anticancer therapy, 2014, Volume: 14, Issue:7

    Topics: Antineoplastic Agents; Central Nervous System Diseases; Cisplatin; Cytarabine; Fluorouracil; Humans; Ifosfamide; Methotrexate; Neurotoxicity Syndromes; Posterior Leukoencephalopathy Syndrome; Vidarabine; Vincristine

2014
Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:3

    Topics: Antineoplastic Agents; Hematopoietic Stem Cell Transplantation; Humans; Leukoencephalopathies; Posterior Leukoencephalopathy Syndrome; Prodrugs; Vidarabine

2011

Other Studies

1 other study(ies) available for fludarabine and Leukoencephalopathy Syndrome, Posterior

ArticleYear
Cyclosporine-related posterior reversible encephalopathy syndrome after cord blood stem cell transplantation.
    Hematology/oncology and stem cell therapy, 2013, Volume: 6, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Radiography; Vidarabine; Whole-Body Irradiation

2013